
SI Stock Forecast & Price Target
SI Analyst Ratings
Bulls say
Shoulder Innovations is expected to launch three new products in the next year that could expand its total addressable market by $200 million or more. With a strong track record of growth and a robust portfolio designed to address surgeon needs, the company is poised for upside to consensus estimates and potential market share gains. Furthermore, its partnership for a lower-cost, minimally invasive robotic device positions the company well for future growth.
Bears say
Shoulder Innovations is currently trading below its IPO price and has seen a decline in share price despite strong Q4 results, likely due to a broader sector rotation out of smaller cap MedTech stocks. However, with a promising pipeline and expected growth in sales from new product launches and increased utilization within existing surgeon accounts, the company may have long-term potential. While its current valuation is relatively low compared to peers, risks to the stock include potential difficulties with acquisitions, competition in the robotics market, and challenges in the supply chain.
This aggregate rating is based on analysts' research of Shoulder Innovations LLC and is not a guaranteed prediction by Public.com or investment advice.
SI Analyst Forecast & Price Prediction
Start investing in SI
Order type
Buy in
Order amount
Est. shares
0 shares